GENEVA, July 1 -- ASTELLAS PHARMA INC. filed a patent application (JP2025/043046) for “FEZOLINETANT FOR USE IN METHODS FOR TREATING VASOMOTOR SYMPTOMS IN PROSTATE CANCER PATIENTS”. With publication no. WO/2026/127052, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/167
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....